Quitting smoking in pregnancy benefits baby's temperament

Article

Quitting smoking during pregnancy reduces a mother's chances of giving birth to a baby with problem behavior.

Quitting smoking during pregnancy reduces a mother's chances of giving birth to a baby with problem behavior, according to a study published in the April issue of the Journal of Epidemiology and Community Health.

Kate E. Pickett, PhD, of the University of York in the United Kingdom, and colleagues analyzed data on over 18,000 infants whose mothers were classified as pregnancy nonsmokers, quitters, and light or heavy smokers. Heavy smoking was classified as at least 10 cigarettes a day. The infants were assessed in terms of temperament, receptivity to novelty, and regularity.

The lowest scores for easy temperament were found among babies whose mothers were heavy smokers, and babies of mothers who quit during pregnancy scored the highest, the investigators found. Smoking during pregnancy was also associated with low positive mood, while quitting during pregnancy was associated with lower risk of distress to novelty and irregularity.

Pickett KE, Wood C, Adamson J, et al. Meaningful differences in maternal smoking behaviour during pregnancy: implications for infant behavioural vulnerability. J Epidemiol Community Health. 2008;62:318-324. doi:10.1136/jech.2006.058768.

Recent Videos
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Empowering women to take charge of their health | Image Credit: © piecesofi.com - © piecesofi.com - stock.adobe.com.
Supporting women through menopause with knowledge and care | Image Credit: © SHOTPRIME STUDIO - © SHOTPRIME STUDIO - stock.adobe.com.
How fezolinetant revolutionizes non-hormonal menopause therapy | Image Credit: imsociety.org
Gulf War exposures linked to early menopause in women veterans | Image Credit: linkedin.com.
Vanessa Muñiz discusses benefits of clinical hypnosis against hot flashes | Image Credit: mindbodymedicine.artsandsciences.baylor.edu
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
© 2024 MJH Life Sciences

All rights reserved.